Adamax is an experimental peptide derived from Semax by adding an N-terminal acetyl group and a C-terminal adamantane moiety. This comparative analysis exa
Read more Adamax vs. Semax: Chemical Modifications, Preclinical Research, and Evidence Gaps
Adamax is an experimental peptide derived from Semax by adding an N-terminal acetyl group and a C-terminal adamantane moiety. This comparative analysis exa
Read more Adamax vs. Semax: Chemical Modifications, Preclinical Research, and Evidence Gaps
Semax is a synthetic ACTH(4-7) analog investigated for acute ischemic stroke and neurological rehabilitation. Research demonstrates that it upregulates BDN
Read more Semax in Ischemic Stroke Research: Mechanisms and Clinical Trials
A comprehensive, evidence-tiered analysis of Adamax peptide—evaluating its adamantane-modified Semax structure, proposed neurotrophic mechanisms, and curre
Read more Adamax Peptide: Neurotrophic Mechanisms, Pharmacology, and Scientific Evidence
Semax is a synthetic ACTH(4-10) analog that exhibits potent neuroprotective, neurotrophic, and cognitive-modulating properties across clinical and pre-clin
Read more Semax Research Guide: Mechanisms, Neurotrophic Actions, and Clinical Evidence